carbenoxolone sodium has been researched along with Dry Eye in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, KJ; Jung, WH; Kim, HY; Kim, KY; Na, YJ; Park, SB; Rhee, SD; Sung, HR | 1 |
1 other study(ies) available for carbenoxolone sodium and Dry Eye
Article | Year |
---|---|
Protective effects of carbenoxolone, an 11β-HSD1 inhibitor, against chemical induced dry eye syndrome.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Animals; Apoptosis; bcl-2-Associated X Protein; Benzalkonium Compounds; Carbenoxolone; Cell Line; Conjunctiva; Dose-Response Relationship, Drug; Dry Eye Syndromes; Enzyme Inhibitors; Epithelial Cells; Gene Expression Regulation; Humans; Interleukin-6; Male; Ophthalmic Solutions; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Signal Transduction; Tumor Necrosis Factor-alpha | 2017 |